{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2026-01-23T12:27:55.332703+00:00",
  "news": [
    {
      "title": "Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQanFXN3RpOU5Pam9TSmNabkVXNTJGbS1HLWxGVE95THRNNG93RHdmU3NnM2dubGs5ck1LVkdxUVpfX1JacFdiMUVKRV9BLXduaXZiRVR4OFRCTU5CazNfU24xZ245T09kaG5iUGlsal9KUkFHRUltZE9EME5ZNW5fZFFHaGhWU0l3LTl0VFBwM0wtdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxQanFXN3RpOU5Pam9TSmNabkVXNTJGbS1HLWxGVE95THRNNG93RHdmU3NnM2dubGs5ck1LVkdxUVpfX1JacFdiMUVKRV9BLXduaXZiRVR4OFRCTU5CazNfU24xZ245T09kaG5iUGlsal9KUkFHRUltZE9EME5ZNW5fZFFHaGhWU0l3LTl0VFBwM0wtdw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-22T23:00:05+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Responsibility | Grants and Giving - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPempkZnJfemR2dHhGT3ZsRkJ0UDdUZ0pUUURUczhJS0I3N1JMVS04YmpRNGF0UXA2dmxFVF9seXZXRlFBUW5ZUmNZX0pGNHQ4VGFIMFFvSFhNX3VaUHA1Rm44T2pLbUctMDV6LWdXeHlzaWV4cHRIXzlvSjVwM3VkaVdxTnZKemluVC1KZUhrUHQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxPempkZnJfemR2dHhGT3ZsRkJ0UDdUZ0pUUURUczhJS0I3N1JMVS04YmpRNGF0UXA2dmxFVF9seXZXRlFBUW5ZUmNZX0pGNHQ4VGFIMFFvSFhNX3VaUHA1Rm44T2pLbUctMDV6LWdXeHlzaWV4cHRIXzlvSjVwM3VkaVdxTnZKemluVC1KZUhrUHQ?oc=5\" target=\"_blank\">Responsibility | Grants and Giving</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2026-01-21T19:40:49+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Inogen (INGN) - The Globe and Mail",
      "link": "https://news.google.com/rss/articles/CBMiiwJBVV95cUxONUFZd3N3OTFDejZEQklFTEd6bEFZZ2xaQ0dNZ1RvNGpOLUppLXZLcnZMUDRHaHg1UEpHcGJEUi1MUjdkVkNtWHNPOFJXTU1qaEJTSHcxLXJ2QzJxcTBicEdjZzBNclBGdEhDRGZfcy1kZFVaRFJ4OVZJWFMzU0hyQXlkUmVpaHNqN3BpREE1Wmw1dHp1XzJVUXAxalZKRTU2UFpvMWowMEpWcU9zd2g2YjZodFRBbmtJdE05N0hQeHMzZjM0MTROcDQ2RENrVXktYlhpN2R6SDJOWXEyYzFWMEN4d3RPVHlPNzBUd2JhN2pPOUtTUTVlcFZHelNFek44Qzc0bVNhdC1VWjQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwJBVV95cUxONUFZd3N3OTFDejZEQklFTEd6bEFZZ2xaQ0dNZ1RvNGpOLUppLXZLcnZMUDRHaHg1UEpHcGJEUi1MUjdkVkNtWHNPOFJXTU1qaEJTSHcxLXJ2QzJxcTBicEdjZzBNclBGdEhDRGZfcy1kZFVaRFJ4OVZJWFMzU0hyQXlkUmVpaHNqN3BpREE1Wmw1dHp1XzJVUXAxalZKRTU2UFpvMWowMEpWcU9zd2g2YjZodFRBbmtJdE05N0hQeHMzZjM0MTROcDQ2RENrVXktYlhpN2R6SDJOWXEyYzFWMEN4d3RPVHlPNzBUd2JhN2pPOUtTUTVlcFZHelNFek44Qzc0bVNhdC1VWjQ?oc=5\" target=\"_blank\">Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Inogen (INGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Globe and Mail</font>",
      "published": "2026-01-23T10:23:43+00:00",
      "source": "The Globe and Mail"
    },
    {
      "title": "RBC Capital Upgrades Vertex Pharmaceuticals (VRTX) - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPM1NESC1OalIxRDF6WmMxVldPaGVRQ3FPRk9USmc5MkdvTGNwdHNDVnZ5cXhvcEhsVDdJYXpKZEk5MzNGbGF4bW5Yb2p2cTBWdnpzV0JCVjRVQjBYMGZIVGREZmRVSUlDeER1dEVMaTA0ekdOZkxVX3dlVjloZlF4TWJJSUhZLVU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxPM1NESC1OalIxRDF6WmMxVldPaGVRQ3FPRk9USmc5MkdvTGNwdHNDVnZ5cXhvcEhsVDdJYXpKZEk5MzNGbGF4bW5Yb2p2cTBWdnpzV0JCVjRVQjBYMGZIVGREZmRVSUlDeER1dEVMaTA0ekdOZkxVX3dlVjloZlF4TWJJSUhZLVU?oc=5\" target=\"_blank\">RBC Capital Upgrades Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2026-01-23T00:02:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "Vertex Pharma upgraded at RBC Capital Markets citing upside in 2026 - MSN",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxORUh1M3lXV1VZNVZIX01hOENoZ1N3a1E0cDZiRU5YblBpQjhSNUlBVURkdGVKM05BUC1jS09UVXZ4ZU9kVjRjS05zRXhvSkJCVmJZd0haR2lXcXA3SkhiTkFsWlAzU2FFc2J0SjhHQ0FuTUZ0LTB4cFhZVXl3OW9RaGNMWmJjRnFCVWtzdjdwWGlKYk1vR190cUUyTUxYRC1EeWhyeGp2T2FsYnhjSnZWY2RFelVQbHc1V1dlRVJB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxORUh1M3lXV1VZNVZIX01hOENoZ1N3a1E0cDZiRU5YblBpQjhSNUlBVURkdGVKM05BUC1jS09UVXZ4ZU9kVjRjS05zRXhvSkJCVmJZd0haR2lXcXA3SkhiTkFsWlAzU2FFc2J0SjhHQ0FuTUZ0LTB4cFhZVXl3OW9RaGNMWmJjRnFCVWtzdjdwWGlKYk1vR190cUUyTUxYRC1EeWhyeGp2T2FsYnhjSnZWY2RFelVQbHc1V1dlRVJB?oc=5\" target=\"_blank\">Vertex Pharma upgraded at RBC Capital Markets citing upside in 2026</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2026-01-22T16:24:34+00:00",
      "source": "MSN"
    },
    {
      "title": "Evercore ISI raises Vertex stock price target to $530 on povetacicept potential - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNZkxBaFRlMU5XUVZUdHdDcFRaMXRlbGFQcEl4NzBEdHJwbXNqWVlsakdrMXUzTnFhbWJzeDNNZU0yQ1U2UUNVYzNLaHhVNmNYR0JIV0hhNml1c2JESU5CWlJoa3lXcm51Q3N4X3VycFhqSmUxVndwWTV3V3Rra3Nsd3hnZnFJWUxZZUdJMGJEUTdSUDRfdUlVdXNkRks2RF9mRHY0bXRwWHM0RmsxcWNxLTdTcklMcnFUaDJFdUR6Q25QUjJXSnlLTFFRWU9WQk1fMllkZQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNZkxBaFRlMU5XUVZUdHdDcFRaMXRlbGFQcEl4NzBEdHJwbXNqWVlsakdrMXUzTnFhbWJzeDNNZU0yQ1U2UUNVYzNLaHhVNmNYR0JIV0hhNml1c2JESU5CWlJoa3lXcm51Q3N4X3VycFhqSmUxVndwWTV3V3Rra3Nsd3hnZnFJWUxZZUdJMGJEUTdSUDRfdUlVdXNkRks2RF9mRHY0bXRwWHM0RmsxcWNxLTdTcklMcnFUaDJFdUR6Q25QUjJXSnlLTFFRWU9WQk1fMllkZQ?oc=5\" target=\"_blank\">Evercore ISI raises Vertex stock price target to $530 on povetacicept potential</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2026-01-23T10:41:18+00:00",
      "source": "Investing.com"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Upgraded on Strong Cystic Fibrosis Franchise - GuruFocus",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNUVcxeU8wVVlUSjlNZ3JidVk5ZUpFZ3NpTVZyM2s0WFROUEd6TlVOWXRQVE9BMUlYeUR1UkJaNmtmVUVWaEktd3lBV2pYa1M4dzZMMUhmMlRJN1gtaXo0R1RxOXhFRzlJZE9nTTlKYmVsMHZlUkJ0U1ZaakNJVTBhX0FzSVFSS191aDVodFZfVThVVHJ1aXYtaWFmWkV3VW9rSUNxVzZWYnR4eWN5bWFhYkRGSGVnMXlDcVhGNTFCc3U?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNUVcxeU8wVVlUSjlNZ3JidVk5ZUpFZ3NpTVZyM2s0WFROUEd6TlVOWXRQVE9BMUlYeUR1UkJaNmtmVUVWaEktd3lBV2pYa1M4dzZMMUhmMlRJN1gtaXo0R1RxOXhFRzlJZE9nTTlKYmVsMHZlUkJ0U1ZaakNJVTBhX0FzSVFSS191aDVodFZfVThVVHJ1aXYtaWFmWkV3VW9rSUNxVzZWYnR4eWN5bWFhYkRGSGVnMXlDcVhGNTFCc3U?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Upgraded on Strong Cystic Fibrosis Franchise</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
      "published": "2026-01-22T19:04:52+00:00",
      "source": "GuruFocus"
    },
    {
      "title": "Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded to Outperform at Royal Bank Of Canada - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQWVBGTEMyVEhqcWtjTlQzNV9GZVFUdTRWZDhvTGttTDNiRjYwa2Z2Zk5sck9iRzdlTW9MdnVPdUNzWlBoa1FwWk5aOElVeDJIZ2J3ZWZyLVktaEFkVkhRY1NsS2xRcDA1LU1WYjRhSUpsUW9IUmxXelF1eld3SG83YnQ2MVVZeDBpM2czWWxadGpyc3VrLVN1UXJVX0o5QXItcXhMV244VjUxOG8zX1N3RlhfTDFyeERNemhjdWFWTzJDWTRObGxITUh4WWFkMzQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizwFBVV95cUxQWVBGTEMyVEhqcWtjTlQzNV9GZVFUdTRWZDhvTGttTDNiRjYwa2Z2Zk5sck9iRzdlTW9MdnVPdUNzWlBoa1FwWk5aOElVeDJIZ2J3ZWZyLVktaEFkVkhRY1NsS2xRcDA1LU1WYjRhSUpsUW9IUmxXelF1eld3SG83YnQ2MVVZeDBpM2czWWxadGpyc3VrLVN1UXJVX0o5QXItcXhMV244VjUxOG8zX1N3RlhfTDFyeERNemhjdWFWTzJDWTRObGxITUh4WWFkMzQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded to Outperform at Royal Bank Of Canada</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-01-22T13:58:09+00:00",
      "source": "MarketBeat"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2026-01-22",
      "close": 467.3500061035156
    },
    "history": [
      {
        "date": "2026-01-13",
        "close": 454.6700134277344
      },
      {
        "date": "2026-01-14",
        "close": 449.5299987792969
      },
      {
        "date": "2026-01-15",
        "close": 438.9200134277344
      },
      {
        "date": "2026-01-16",
        "close": 441.3599853515625
      },
      {
        "date": "2026-01-20",
        "close": 442.0799865722656
      },
      {
        "date": "2026-01-21",
        "close": 461.1400146484375
      },
      {
        "date": "2026-01-22",
        "close": 467.3500061035156
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}